Intrapulmonary thrombolytic therapy in a child with acute pulmonary embolism due to primary antiphospholipid syndrome

Hsin Ju Huang, Jieh Neng Wang, Yu Chien Tsai, Chia Shiang Lin, Jing Ming Wu

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Pulmonary embolism (PE) is a rare but life-threatening condition, which needs emergent treatment in children. Though anticoagulation is the standard treatment for PE, recent studies revealed intrapulmonary thrombolytic therapy may produce more rapid clot lysis and less systemic complications in adult patients. We reported a 10-year-old girl who had diffused multiple pulmonary emboli due to primary antiphospholipid syndrome. The thrombi persisted in spite of intravenous heparin infusion for 3 days, which resolved quickly after intrapulmonary streptokinase infusion for 12 hours.

Original languageEnglish
Pages (from-to)351-353
Number of pages3
JournalActa Paediatrica Taiwanica
Volume43
Issue number6
Publication statusPublished - 2002 Nov

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Intrapulmonary thrombolytic therapy in a child with acute pulmonary embolism due to primary antiphospholipid syndrome'. Together they form a unique fingerprint.

Cite this